相关实验视频

Updated: Jun 5, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

290

免疫检查点及其在T细胞淋巴瘤中的抑制

Jana Seňavová1,2, Anežka Rajmonová2, Václav Heřman1,2

  • 11st Department of Medicine - Department of Haematology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.

Folia biologica
|December 7, 2024
PubMed
概括

免疫检查点抑制剂 (ICI) 在治疗T细胞淋巴瘤 (TCLs),一种罕见的癌症方面表现有前途. 然而,需要进一步的研究来优化它们的使用,并解决潜在的风险,如超级进展和二次恶性瘤.

关键词:
在ALCL和ALCL之间.在 CTLA-4 中.这是一个 ENKTLTL ENKTL.现场行动组-3许多金融机构的MFOX40/OX40L 的时间.在PD-1中使用PD-1.在PD-L1中.在PTCL中,PTCL是什么?这就是SSSSSSSS的原因.塞萨里综合征是什么意思这是一种T细胞淋巴瘤.来自T细胞的恶性瘤这是一个紧张的紧张.在TIM-3中,TIM-3是TIM-3.形性大细胞淋巴瘤这是一种抗CTLA-4的药物.这是一种抗PD-1药物.这是一种抗PD-L1的药物.它们是Atezolizumab.在此之前,Avelumab.达尔瓦卢马布 (Durvalumab) 是一种耐药的药物.额外的NK/T细胞淋巴瘤.盖普塔诺利马布 (geptanolimab) 是一种免疫检查点抑制剂 免疫检查点抑制剂免疫检查点的检查点.一个不错的例子是 ipilimumab.菌菌病 菌病 菌病这就是尼沃卢马布 (nivolumab).这就是Pembrolizumab.周围T细胞淋巴瘤这种感觉是不可思议的.托里帕利马巴姆 (Toripalimab) 是一个

更多相关视频

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.4K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

643

相关概念视频

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
658
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
846